Harvard Apparatus Regenerative Technology, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Harvard Apparatus Regenerative Technology, Inc. (HRGN) reported Net Income (Loss) Available to Common Stockholders, Basic of -$7.73 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2025-03-31
- Harvard Apparatus Regenerative Technology, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-12-31 was -$1.34M.
- Harvard Apparatus Regenerative Technology, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-09-30 was -$1.86M.
- Harvard Apparatus Regenerative Technology, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-06-30 was -$2.50M.
- Harvard Apparatus Regenerative Technology, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-03-31 was -$2.03M.
- Harvard Apparatus Regenerative Technology, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$7.73M.
- Harvard Apparatus Regenerative Technology, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$9.02M.
- Harvard Apparatus Regenerative Technology, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$6.25M.
- Harvard Apparatus Regenerative Technology, Inc. net income (loss) available to common stockholders, basic for fiscal 2021 was -$7.98M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.20M derived: sum of 2 quarters · filed 2025-03-31 | -$5.70M derived: sum of 3 quarters · filed 2025-03-31 | -$7.73M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$1.86M 10-Q · filed 2024-11-13 | -$4.36M derived: sum of 2 quarters · filed 2024-11-13 | -$6.39M 10-Q · filed 2024-11-13 | -$8.21M derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | -$2.50M 10-Q · filed 2024-08-13 | -$4.53M 10-Q · filed 2024-08-13 | -$6.35M derived: sum of 3 quarters · filed 2025-03-31 | -$7.97M derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | -$2.03M 10-Q · filed 2024-05-13 | -$3.86M derived: sum of 2 quarters · filed 2025-03-31 | -$5.47M derived: sum of 3 quarters · filed 2025-03-31 | -$8.08M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.44M derived: sum of 2 quarters · filed 2025-03-31 | -$6.05M derived: sum of 3 quarters · filed 2025-03-31 | -$9.02M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$1.61M 10-Q · filed 2024-11-13 | -$4.23M derived: sum of 2 quarters · filed 2024-11-13 | -$7.20M 10-Q · filed 2024-11-13 | -$8.78M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$2.61M 10-Q · filed 2024-08-13 | -$5.58M 10-Q · filed 2024-08-13 | -$7.16M derived: sum of 3 quarters · filed 2024-08-13 | -$8.29M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$2.97M 10-Q · filed 2024-05-13 | -$4.55M derived: sum of 2 quarters · filed 2024-05-13 | -$5.68M derived: sum of 3 quarters · filed 2024-05-13 | -$7.05M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$2.71M derived: sum of 2 quarters · filed 2024-03-28 | -$4.08M derived: sum of 3 quarters · filed 2024-03-28 | -$6.25M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$1.13M 10-Q · filed 2023-11-13 | -$2.50M derived: sum of 2 quarters · filed 2023-11-13 | -$4.67M 10-Q · filed 2023-11-13 | -$10.55M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$1.36M 10-Q · filed 2023-08-14 | -$3.54M 10-Q · filed 2023-08-14 | -$9.41M derived: sum of 3 quarters · filed 2023-08-14 | -$10.26M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$2.18M 10-Q · filed 2023-05-12 | -$8.05M derived: sum of 2 quarters · filed 2023-05-12 | -$8.90M derived: sum of 3 quarters · filed 2023-05-12 | -$9.28M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$6.72M derived: sum of 2 quarters · filed 2023-03-30 | -$7.10M derived: sum of 3 quarters · filed 2023-03-30 | -$7.98M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$849.00K 10-Q · filed 2022-11-14 | -$1.23M derived: sum of 2 quarters · filed 2022-11-14 | -$2.10M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$382.00K 10-Q · filed 2022-08-04 | -$1.26M 10-Q · filed 2022-08-04 |